SIMILAR PATTERNS OF AMINO ACIDS FOR 4QWU_V_BO2V301_1

List of similar pattern of amino acids derived from ASSAM search

Hit pattern: 3D amino acid arrangements similar to known drug binding site

Query pattern: Residues from known binding site for annotated drug that match the hit pattern


(Click link on the last column to view superposed patterns of amino acids in NGL viewer)
(Note that only 3-12 residue patterns can be used for ASSAM searches)
Filter list by:
Hit Macromolecule/
Organism
Pfam Res. Interface HETATM RMSD Dali Z-score Seq. Identity (%) View Dock
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1c4k PROTEIN (ORNITHINE
DECARBOXYLASE)


(Lactobacillus
sp. 30A)
PF01276
(OKR_DC_1)
PF03709
(OKR_DC_1_N)
PF03711
(OKR_DC_1_C)
5 THR A 243
GLN A 612
GLY A 252
THR A 291
ASP A 535
None
1.15A 4qwuV-1c4kA:
undetectable
4qwuW-1c4kA:
0.0
4qwuV-1c4kA:
17.71
4qwuW-1c4kA:
15.96
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1i9r IMMUNOGLOBULIN H

(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 193
GLY H 139
THR H 140
ALA H 141
THR H 136
None
0.85A 4qwuV-1i9rH:
0.0
4qwuW-1i9rH:
0.2
4qwuV-1i9rH:
21.32
4qwuW-1i9rH:
21.99
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1pkq (8-18C5) CHIMERIC
FAB, HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
5 SER B 188
GLY B 134
THR B 135
ALA B 136
THR B 131
None
0.90A 4qwuV-1pkqB:
undetectable
4qwuW-1pkqB:
undetectable
4qwuV-1pkqB:
20.74
4qwuW-1pkqB:
24.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1q5q PROTEASOME BETA-TYPE
SUBUNIT 1


(Rhodococcus
erythropolis)
PF00227
(Proteasome)
5 THR H   1
LYS H  33
GLY H  47
THR H  48
ALA H  49
None
0.33A 4qwuV-1q5qH:
25.7
4qwuW-1q5qH:
24.5
4qwuV-1q5qH:
26.48
4qwuW-1q5qH:
26.64
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1rzg FAB 412D LIGHT CHAIN

(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER A 188
GLY A 134
THR A 135
ALA A 136
THR A 131
None
0.96A 4qwuV-1rzgA:
undetectable
4qwuW-1rzgA:
undetectable
4qwuV-1rzgA:
21.74
4qwuW-1rzgA:
23.17
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1um4 ANTIBODY 21H3 H
CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 194
GLY H 140
THR H 141
ALA H 142
THR H 137
None
0.84A 4qwuV-1um4H:
undetectable
4qwuW-1um4H:
undetectable
4qwuV-1um4H:
22.45
4qwuW-1um4H:
24.79
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uwe ANTIBODY 14D9

(Homo sapiens;
Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.88A 4qwuV-1uweH:
0.0
4qwuW-1uweH:
undetectable
4qwuV-1uweH:
22.48
4qwuW-1uweH:
23.63
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1uxz CELLULASE B

(Cellvibrio
mixtus)
PF03422
(CBM_6)
5 GLY A  91
THR A  94
ALA A  62
THR A  89
ASP A  24
None
1.23A 4qwuV-1uxzA:
undetectable
4qwuW-1uxzA:
undetectable
4qwuV-1uxzA:
20.17
4qwuW-1uxzA:
20.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
1zps PHOSPHORIBOSYL-AMP
CYCLOHYDROLASE


(Methanothermobacter
thermautotrophicus)
PF01502
(PRA-CH)
5 GLN A  97
GLY A  54
THR A  55
ALA A  56
THR A  50
None
1.42A 4qwuV-1zpsA:
undetectable
4qwuW-1zpsA:
undetectable
4qwuV-1zpsA:
21.12
4qwuW-1zpsA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2b4c ANTI-HIV-1 GP120
IMMUNOGLOBULIN X5
HEAVY CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.93A 4qwuV-2b4cH:
undetectable
4qwuW-2b4cH:
undetectable
4qwuV-2b4cH:
20.72
4qwuW-2b4cH:
21.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2eh7 HUMANIZED KR127 FAB,
HEAVY CHAIN


(Mus musculus)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.94A 4qwuV-2eh7H:
undetectable
4qwuW-2eh7H:
undetectable
4qwuV-2eh7H:
21.43
4qwuW-2eh7H:
22.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fhg PROTEASOME, BETA
SUBUNIT


(Mycobacterium
tuberculosis)
no annotation 6 THR H 301
SER H 320
GLN H 322
LYS H 333
GLY H 347
ALA H 349
None
0.86A 4qwuV-2fhgH:
25.1
4qwuW-2fhgH:
24.0
4qwuV-2fhgH:
26.85
4qwuW-2fhgH:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2fhg PROTEASOME, BETA
SUBUNIT


(Mycobacterium
tuberculosis)
no annotation 6 THR H 301
SER H 320
LYS H 333
GLY H 347
THR H 348
ALA H 349
None
0.41A 4qwuV-2fhgH:
25.1
4qwuW-2fhgH:
24.0
4qwuV-2fhgH:
26.85
4qwuW-2fhgH:
23.05
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
2gre DEBLOCKING
AMINOPEPTIDASE


(Bacillus cereus)
PF05343
(Peptidase_M42)
5 THR A 334
SER A 190
GLY A 316
THR A 326
ASP A 186
None
1.32A 4qwuV-2greA:
undetectable
4qwuW-2greA:
undetectable
4qwuV-2greA:
20.22
4qwuW-2greA:
20.57
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3brs PERIPLASMIC BINDING
PROTEIN/LACI
TRANSCRIPTIONAL
REGULATOR


(Lachnoclostridium
phytofermentans)
PF13407
(Peripla_BP_4)
5 GLY A 204
THR A 203
ALA A 202
ASP A 224
CYH A 222
None
1.46A 4qwuV-3brsA:
undetectable
4qwuW-3brsA:
undetectable
4qwuV-3brsA:
20.32
4qwuW-3brsA:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3brs PERIPLASMIC BINDING
PROTEIN/LACI
TRANSCRIPTIONAL
REGULATOR


(Lachnoclostridium
phytofermentans)
PF13407
(Peripla_BP_4)
5 THR A 181
GLY A 204
THR A 203
ALA A 202
ASP A 224
None
1.32A 4qwuV-3brsA:
undetectable
4qwuW-3brsA:
undetectable
4qwuV-3brsA:
20.32
4qwuW-3brsA:
21.68
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3d85 FAB OF ANTIBODY
7G10, HEAVY CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER B 190
GLY B 136
THR B 137
ALA B 138
THR B 133
None
0.80A 4qwuV-3d85B:
undetectable
4qwuW-3d85B:
undetectable
4qwuV-3d85B:
22.01
4qwuW-3d85B:
23.01
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3ifr CARBOHYDRATE KINASE,
FGGY


(Rhodospirillum
rubrum)
PF00370
(FGGY_N)
PF02782
(FGGY_C)
5 GLY A 305
THR A 304
ALA A 268
ASP A 270
CYH A 300
None
1.46A 4qwuV-3ifrA:
undetectable
4qwuW-3ifrA:
undetectable
4qwuV-3ifrA:
20.04
4qwuW-3ifrA:
18.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3lyk STRINGENT STARVATION
PROTEIN A HOMOLOG


(Haemophilus
influenzae)
PF00043
(GST_C)
PF02798
(GST_N)
5 GLY A  57
THR A  58
THR A  61
ASP A  19
CYH A  22
None
1.27A 4qwuV-3lykA:
undetectable
4qwuW-3lykA:
undetectable
4qwuV-3lykA:
21.69
4qwuW-3lykA:
19.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3mg6 PROTEASOME COMPONENT
PRE3


(Saccharomyces
cerevisiae)
no annotation 5 THR N   1
LYS N  33
GLY N  47
ALA N  49
THR N  52
None
0.66A 4qwuV-3mg6N:
29.3
4qwuW-3mg6N:
27.6
4qwuV-3mg6N:
29.49
4qwuW-3mg6N:
23.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3oaz FAB 2G12, HEAVY
CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 197
GLY H 136
THR H 137
ALA H 138
THR H 133
None
0.92A 4qwuV-3oazH:
undetectable
4qwuW-3oazH:
undetectable
4qwuV-3oazH:
20.32
4qwuW-3oazH:
23.27
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3qpx FAB C2507 HEAVY
CHAIN


(Homo sapiens;
Rattus
norvegicus)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 194
GLY H 140
THR H 141
ALA H 142
THR H 137
None
0.84A 4qwuV-3qpxH:
undetectable
4qwuW-3qpxH:
undetectable
4qwuV-3qpxH:
20.90
4qwuW-3qpxH:
22.36
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3tkk PREDICTED
ACETAMIDASE/FORMAMID
ASE


(Caldanaerobacter
subterraneus)
PF03069
(FmdA_AmdA)
5 CYH A  37
GLY A 193
THR A  92
ALA A  91
ASP A  50
ZN  A 301 ( 3.2A)
None
None
None
None
1.40A 4qwuV-3tkkA:
undetectable
4qwuW-3tkkA:
undetectable
4qwuV-3tkkA:
21.47
4qwuW-3tkkA:
23.13
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
3unf PROTEASOME SUBUNIT
BETA TYPE-10


(Mus musculus)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
6 THR H   1
CYH H  31
LYS H  33
GLY H  47
ALA H  49
THR H  52
04C  H 301 (-2.5A)
04C  H 301 ( 3.7A)
04C  H 301 (-3.5A)
04C  H 301 (-3.7A)
04C  H 301 (-3.6A)
04C  H 301 (-3.8A)
0.62A 4qwuV-3unfH:
35.8
4qwuW-3unfH:
28.8
4qwuV-3unfH:
46.78
4qwuW-3unfH:
23.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3w0l GLUCOKINASE
REGULATORY PROTEIN


(Xenopus laevis)
no annotation 5 GLY B 441
THR B 439
ALA B 438
THR B 459
ASP B 412
None
1.48A 4qwuV-3w0lB:
undetectable
4qwuW-3w0lB:
undetectable
4qwuV-3w0lB:
17.80
4qwuW-3w0lB:
16.81
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
3wiq KOJIBIOSE
PHOSPHORYLASE


(Caldicellulosiruptor
saccharolyticus)
PF03632
(Glyco_hydro_65m)
PF03633
(Glyco_hydro_65C)
PF03636
(Glyco_hydro_65N)
5 THR A 658
SER A 632
GLN A 597
GLY A 681
ALA A 677
None
SO4  A 803 (-3.0A)
GLC  A 801 (-3.2A)
None
None
1.25A 4qwuV-3wiqA:
undetectable
4qwuW-3wiqA:
0.7
4qwuV-3wiqA:
16.69
4qwuW-3wiqA:
14.15
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ayz HEME-BINDING PROTEIN
2


(Homo sapiens)
PF04832
(SOUL)
5 THR A  51
GLY A  65
THR A  64
ALA A  61
ASP A  57
None
1.50A 4qwuV-4ayzA:
undetectable
4qwuW-4ayzA:
undetectable
4qwuV-4ayzA:
21.34
4qwuW-4ayzA:
21.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4f88 PLYCA

(Streptococcus
virus C1)
PF05257
(CHAP)
5 THR 1 220
GLN 1 417
CYH 1 333
GLY 1 364
ALA 1 367
None
1.44A 4qwuV-4f881:
undetectable
4qwuW-4f881:
undetectable
4qwuV-4f881:
20.04
4qwuW-4f881:
17.09
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4m7w PURINE NUCLEOSIDE
PHOSPHORYLASE
DEOD-TYPE


(Leptotrichia
buccalis)
PF01048
(PNP_UDP_1)
5 THR A 199
GLY A  90
THR A  91
ALA A  92
ASP A 205
None
PO4  A 400 (-3.6A)
PO4  A 400 (-3.5A)
None
None
1.44A 4qwuV-4m7wA:
undetectable
4qwuW-4m7wA:
undetectable
4qwuV-4m7wA:
23.27
4qwuW-4m7wA:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4nlm LMO1340 PROTEIN

(Listeria
monocytogenes)
no annotation 5 THR A 137
SER A  92
THR A 115
ALA A 114
THR A 132
None
1.34A 4qwuV-4nlmA:
undetectable
4qwuW-4nlmA:
undetectable
4qwuV-4nlmA:
19.11
4qwuW-4nlmA:
20.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4oaw HEAVY CHAIN OF FAB
FRAGMENT OF
ANTI-HIV1 GP120 V2
MAB 2158


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER B 205
GLY B 151
THR B 152
ALA B 153
THR B 148
None
0.88A 4qwuV-4oawB:
undetectable
4qwuW-4oawB:
undetectable
4qwuV-4oawB:
21.84
4qwuW-4oawB:
23.32
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ocw CAP256-VRC26.06
HEAVY CHAIN


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.87A 4qwuV-4ocwH:
undetectable
4qwuW-4ocwH:
undetectable
4qwuV-4ocwH:
22.34
4qwuW-4ocwH:
23.31
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
4ye4 HEAVY CHAIN HUMAN
ANTIBODY HJ16


(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 202
GLY H 148
THR H 149
ALA H 150
THR H 145
None
0.76A 4qwuV-4ye4H:
undetectable
4qwuW-4ye4H:
undetectable
4qwuV-4ye4H:
24.22
4qwuW-4ye4H:
23.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5a5t EUKARYOTIC
TRANSLATION
INITIATION FACTOR 3
SUBUNIT F


(Oryctolagus
cuniculus)
PF01398
(JAB)
PF13012
(MitMem_reg)
5 THR F 200
GLY F 196
THR F 195
ALA F 194
THR F 221
None
1.14A 4qwuV-5a5tF:
0.0
4qwuW-5a5tF:
undetectable
4qwuV-5a5tF:
20.33
4qwuW-5a5tF:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5esr HALOALKANE
DEHALOGENASE


(Caulobacter
vibrioides)
PF00561
(Abhydrolase_1)
5 GLY A  31
THR A  32
ALA A  33
THR A  27
ASP A  88
None
1.49A 4qwuV-5esrA:
undetectable
4qwuW-5esrA:
undetectable
4qwuV-5esrA:
22.54
4qwuW-5esrA:
21.84
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5f89 CAP248-2B HEAVY
CHAIN


(Homo sapiens)
no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.86A 4qwuV-5f89H:
undetectable
4qwuW-5f89H:
undetectable
4qwuV-5f89H:
18.60
4qwuW-5f89H:
22.22
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fg9 PROTEASOME SUBUNIT
BETA TYPE-2


(Saccharomyces
cerevisiae)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
8 THR H   1
GLN H  22
CYH H  31
LYS H  33
GLY H  47
THR H  48
ALA H  49
THR H  52
None
0.91A 4qwuV-5fg9H:
37.0
4qwuW-5fg9H:
26.2
4qwuV-5fg9H:
98.31
4qwuW-5fg9H:
23.62
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5fg9 PROTEASOME SUBUNIT
BETA TYPE-2


(Saccharomyces
cerevisiae)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
7 THR H   1
SER H  20
GLN H  22
CYH H  31
LYS H  33
ALA H  49
THR H  52
None
1.00A 4qwuV-5fg9H:
37.0
4qwuW-5fg9H:
26.2
4qwuV-5fg9H:
98.31
4qwuW-5fg9H:
23.62
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5j7u MAJOR CAPSID PROTEIN

(Faustovirus)
PF04451
(Capsid_NCLDV)
5 THR A 350
GLY A 360
THR A 359
ALA A 358
ASP A 129
None
1.34A 4qwuV-5j7uA:
undetectable
4qwuW-5j7uA:
undetectable
4qwuV-5j7uA:
17.77
4qwuW-5j7uA:
15.16
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5jfm ALDEHYDE
DEHYDROGENASE


(Rhodopseudomonas
palustris)
PF00171
(Aldedh)
5 THR A 201
SER A 230
THR A 197
ALA A 226
THR A 144
None
None
1VU  A 601 ( 4.8A)
None
None
1.29A 4qwuV-5jfmA:
undetectable
4qwuW-5jfmA:
undetectable
4qwuV-5jfmA:
20.84
4qwuW-5jfmA:
17.66
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5kan 16.G.07 HEAVY CHAIN

(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER G 203
GLY G 149
THR G 150
ALA G 151
THR G 146
None
1.19A 4qwuV-5kanG:
undetectable
4qwuW-5kanG:
undetectable
4qwuV-5kanG:
21.15
4qwuW-5kanG:
23.58
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5n4g HEAVY CHAIN

(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 190
GLY H 136
THR H 137
ALA H 138
THR H 133
None
0.85A 4qwuV-5n4gH:
undetectable
4qwuW-5n4gH:
undetectable
4qwuV-5n4gH:
23.64
4qwuW-5n4gH:
20.00
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5nqd ARSENITE OXIDASE
LARGE SUBUNIT AIOA
[3FE-4S] CLUSTER,
MO-MOLYBDOPTERIN
COFACTOR-BINDING
ACTIVE SITE
ARSENITE OXIDASE
SMALL SUBUNIT AIOB
RIESKE [2FE-2S]
CLUSTER


(Rhizobium sp.
NT-26)
no annotation 5 GLN B 140
CYH A 291
THR A 242
ALA A 239
THR A 237
None
None
MGD  A2002 (-3.0A)
None
MGD  A2002 (-4.4A)
1.42A 4qwuV-5nqdB:
undetectable
4qwuW-5nqdB:
undetectable
4qwuV-5nqdB:
16.59
4qwuW-5nqdB:
17.93
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
5t0h PROTEASOME SUBUNIT
BETA TYPE-7


(Homo sapiens)
PF00227
(Proteasome)
PF12465
(Pr_beta_C)
7 THR O   1
CYH O  31
LYS O  33
GLY O  47
THR O  48
ALA O  49
THR O  52
None
1.01A 4qwuV-5t0hO:
29.6
4qwuW-5t0hO:
26.2
4qwuV-5t0hO:
56.17
4qwuW-5t0hO:
20.94
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5u3j DH511.1 HEAVY CHAIN

(Homo sapiens)
PF07654
(C1-set)
PF07686
(V-set)
5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.85A 4qwuV-5u3jH:
undetectable
4qwuW-5u3jH:
undetectable
4qwuV-5u3jH:
22.43
4qwuW-5u3jH:
22.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5uem 354NC37 FAB HEAVY
CHAIN


(Homo sapiens)
no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.89A 4qwuV-5uemH:
undetectable
4qwuW-5uemH:
undetectable
4qwuV-5uemH:
15.81
4qwuW-5uemH:
21.13
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5v2d DIOXYGENASE

(Pseudomonas
brassicacearum)
no annotation 5 GLY A  65
THR A 119
ALA A 120
THR A  86
ASP A 137
None
1.42A 4qwuV-5v2dA:
undetectable
4qwuW-5v2dA:
undetectable
4qwuV-5v2dA:
14.29
4qwuW-5v2dA:
16.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wcc VRC 315 02-1F07 FAB
HEAVY CHAIN


(Homo sapiens)
no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.84A 4qwuV-5wccH:
undetectable
4qwuW-5wccH:
undetectable
4qwuV-5wccH:
16.90
4qwuW-5wccH:
17.50
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5wna MAB 3D3 FAB HEAVY
CHAIN


(Homo sapiens)
no annotation 5 SER H 199
GLY H 145
THR H 146
ALA H 147
THR H 142
None
0.85A 4qwuV-5wnaH:
undetectable
4qwuW-5wnaH:
undetectable
4qwuV-5wnaH:
18.50
4qwuW-5wnaH:
21.48
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5x5x FD CHAIN OF
ANTI-OSTEOCALCIN
ANTIBODY KTM219


(Mus musculus)
no annotation 5 SER H 188
GLY H 134
THR H 135
ALA H 136
THR H 131
None
0.75A 4qwuV-5x5xH:
undetectable
4qwuW-5x5xH:
undetectable
4qwuV-5x5xH:
15.09
4qwuW-5x5xH:
19.10
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.
5xnz CRED

(Streptomyces
cremeus)
no annotation 5 SER A 380
GLY A 442
THR A 441
ALA A 440
ASP A 436
None
1.47A 4qwuV-5xnzA:
0.0
4qwuW-5xnzA:
0.4
4qwuV-5xnzA:
15.09
4qwuW-5xnzA:
15.12
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.
6avo PROTEASOME SUBUNIT
BETA TYPE-10


(Homo sapiens)
no annotation 5 THR B   1
CYH B  31
LYS B  33
GLY B  47
ALA B  49
None
1.02A 4qwuV-6avoB:
21.8
4qwuW-6avoB:
20.5
4qwuV-6avoB:
43.40
4qwuW-6avoB:
19.10